| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |